News - 30 Apr 2008
A novel, three-dimensional (3-D) screening method for analyzing interactions between cells and new biomaterials could cut initial search times by more than half, researchers from the National...
News - 20 Aug 2007
University of Arkansas researchers have found a simple, inexpensive way to create a nanowire coating on the surface of biocompatible titanium that can be used to create more effective surfaces for hip...
News - 24 Apr 2007
ULURU Inc. announced that its nanoparticle aggregate technology was presented today at the Society for Biomaterials 2007 Annual Meeting and Exposition. This presentation was given by Dr. John St....
News - 12 Apr 2007
VTT Technical Research Centre of Finland, Tampere University of Technology and Nanofoot Finland Oy have developed a direct-write three-dimensional forming method of biomaterials. The methodology...
Nordson MARCH is the global leader in plasma cleaning and treatment equipment, and plasma applications technology. The company has been engaged in the plasma equipment business for more than 25 years...
Article - 22 May 2008
This article illustrates the suitability of the UVISEL Spectroscopic Phase Modulated Ellipsometer as a very accurate instrument for studying solid solid or solid liquid interface reactions, and...
Article - 25 Nov 2005
CPI is working with the Advanced Materials Research Institute (AMRI) at Northumbria University to develop biocompatible materials and nano-coating capabilities through the establishment of a Closed...
Article - 4 Mar 2004
3DM, Inc. today announced that it's PuraMatrix line of synthetic hydrogels was awarded the annual Excellence in Technology Award in the field of Biomaterial Technology by Frost & Sullivan. Posted...
Article - 17 Jun 2004
Buckytubes have potential applications in fields such as field emitters, conductive polymers, energy storage, molecular electronics, thermal materials, structural composites, fibres and fabrics,...
Article - 23 Aug 2006
The vision for nano-assisted regenerative medicine is the development of cost-effective disease-modifying therapies that will allow for in-situ tissue regeneration.